• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为接受阿片类药物使用障碍治疗的患者提供咨询:COVID-19 时代的远程医疗创新与挑战。

The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.

机构信息

Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; Center for Health Promotion and Health Equity, Brown University, Providence, RI, USA; The Fenway Institute, Fenway Health, Boston, MA, USA.

VICTA, Providence, RI, USA.

出版信息

J Subst Abuse Treat. 2021 Jan;120:108163. doi: 10.1016/j.jsat.2020.108163. Epub 2020 Oct 9.

DOI:10.1016/j.jsat.2020.108163
PMID:33298301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7545305/
Abstract

Historically, federal and state policies have narrowly defined treatment models that have resulted in limited access to and engagement in counseling for individuals receiving medications for opioid use disorder (MOUD; e.g., methadone and buprenorphine). In response to the coronavirus pandemic, outpatient MOUD treatment providers rapidly transitioned from traditional, in-person care delivery models to revised COVID-19 protocols that prioritized telehealth counseling to protect the health of patients and staff and ensure continuity in MOUD care. These telehealth innovations appear to mitigate many of the longstanding barriers to counseling in the traditional system and have the potential to forever alter MOUD care delivery. Drawing on data from a Rhode Island-based clinic, we argue that MOUD counseling is achievable via telehealth and outline the need for, and anticipated benefits of, hybrid telehealth/in-person MOUD treatment models moving forward.

摘要

从历史上看,联邦和州政策狭隘地定义了治疗模式,这导致接受阿片类药物使用障碍(MOUD;例如美沙酮和丁丙诺啡)药物治疗的个人获得咨询服务的机会有限,参与度也有限。为应对冠状病毒大流行,门诊 MOUD 治疗提供者迅速从传统的面对面护理模式转变为修订后的 COVID-19 方案,优先提供远程医疗咨询,以保护患者和工作人员的健康,并确保 MOUD 护理的连续性。这些远程医疗创新似乎缓解了传统系统中许多长期存在的咨询障碍,并有可能彻底改变 MOUD 护理的提供方式。基于罗得岛一家诊所的数据,我们认为远程医疗可以实现 MOUD 咨询,并概述了未来混合远程医疗/面对面 MOUD 治疗模式的必要性和预期收益。

相似文献

1
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.为接受阿片类药物使用障碍治疗的患者提供咨询:COVID-19 时代的远程医疗创新与挑战。
J Subst Abuse Treat. 2021 Jan;120:108163. doi: 10.1016/j.jsat.2020.108163. Epub 2020 Oct 9.
2
An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.考察新冠疫情期间远程医疗政策对农村地区初始阿片类药物使用障碍治疗模式的影响。
J Rural Health. 2021 Jun;37(3):467-472. doi: 10.1111/jrh.12570. Epub 2021 Mar 15.
3
COVID-19 and treating incarcerated populations for opioid use disorder.COVID-19 与治疗监禁人群中的阿片类药物使用障碍
J Subst Abuse Treat. 2021 May;124:108216. doi: 10.1016/j.jsat.2020.108216. Epub 2020 Dec 2.
4
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人的远程医疗服务的接受情况、阿片类药物使用障碍药物的获得和保留情况,以及在 COVID-19 大流行之前和期间的药物治疗过量情况。
JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284.
5
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.COVID-19 的影响以及快速放宽政策以扩大阿片类药物使用障碍(MOUD)药物获取:一项全国退伍军人健康管理局队列研究。
Drug Alcohol Depend. 2022 Dec 1;241:109678. doi: 10.1016/j.drugalcdep.2022.109678. Epub 2022 Nov 1.
6
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.利用远程医疗在 COVID-19 期间和之后改善丁丙诺啡的可及性:罗得岛的快速反应倡议。
J Subst Abuse Treat. 2021 May;124:108283. doi: 10.1016/j.jsat.2021.108283. Epub 2021 Jan 20.
7
Telehealth sustains patient engagement in OUD treatment during COVID-19.远程医疗在 COVID-19 期间维持了阿片类药物使用障碍(OUD)患者的治疗参与度。
J Subst Abuse Treat. 2021 Mar;122:108215. doi: 10.1016/j.jsat.2020.108215. Epub 2020 Nov 24.
8
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.利用药剂师在 COVID-19 大流行期间维持和扩大阿片类药物使用障碍的丁丙诺啡供应。
Am J Health Syst Pharm. 2021 Mar 18;78(7):613-618. doi: 10.1093/ajhp/zxab003.
9
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.临床医生在 COVID-19 大流行期间提供阿片类药物使用障碍药物治疗的观点:定性评估。
J Addict Med. 2023;17(4):e262-e268. doi: 10.1097/ADM.0000000000001156. Epub 2023 Mar 2.
10
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?新冠疫情时代阿片类物质使用障碍的药物治疗:新规定能否改变阿片类药物使用的恶性循环?
J Subst Abuse Treat. 2021 Mar;122:108196. doi: 10.1016/j.jsat.2020.108196. Epub 2020 Nov 14.

引用本文的文献

1
Geographic and Policy Factors Influence Telehealth Availability for Substance Use Disorder Treatment.地理和政策因素影响物质使用障碍治疗的远程医疗可及性。
J Behav Health Serv Res. 2025 Sep 9. doi: 10.1007/s11414-025-09966-y.
2
Association between different modalities of opioid use disorder-related care delivery and opioid use disorder-related patient outcomes: A retrospective cohort study.阿片类物质使用障碍相关护理提供的不同模式与阿片类物质使用障碍相关患者结局之间的关联:一项回顾性队列研究。
Addict Behav Rep. 2025 Feb 2;21:100588. doi: 10.1016/j.abrep.2025.100588. eCollection 2025 Jun.
3
Addressing Occupational Dysfunction via Telehealth: A Scoping Review.通过远程医疗解决职业功能障碍:一项范围综述
Int J Telerehabil. 2025 Jan 15;16(2):e6638. doi: 10.5195/ijt.2024.6638. eCollection 2025.
4
An initial randomized controlled trial of a Combined Medication and Behavioral Activation Treatment (CoMBAT) for people with opioid use disorder.一项针对阿片类物质使用障碍患者的联合药物与行为激活治疗(CoMBAT)的初步随机对照试验。
J Subst Use Addict Treat. 2025 Feb;169:209602. doi: 10.1016/j.josat.2024.209602. Epub 2024 Dec 12.
5
Perceived Barriers and Facilitators of Behavioral-Health Modality Change Adoption During the COVID-19 Pandemic: A Systematic Review.COVID-19大流行期间行为健康模式改变采用的感知障碍与促进因素:一项系统综述
J Multidiscip Healthc. 2024 Dec 3;17:5695-5713. doi: 10.2147/JMDH.S472060. eCollection 2024.
6
Virtual Service Delivery in Mental Health and Substance Use Care: A Systematic Review of Preference Elicitation Studies.心理健康与物质使用护理中的虚拟服务提供:偏好诱导研究的系统评价
Community Ment Health J. 2025 Apr;61(3):440-461. doi: 10.1007/s10597-024-01350-y. Epub 2024 Sep 13.
7
Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study.在美国 HEALing(帮助终结阿片类药物滥用长期危害)社区研究中,减少人们对扩大过量用药教育、纳洛酮分发以及阿片类药物使用障碍治疗药物规模的认知障碍。
Prev Med. 2024 Aug;185:108034. doi: 10.1016/j.ypmed.2024.108034. Epub 2024 Jun 8.
8
Integrating Telehealth and Traditional Care in Chronic Pain Management and Substance Use Disorder Treatment: An Action Agenda for Building the Future State of Hybrid Care.将远程医疗与传统护理整合于慢性疼痛管理和物质使用障碍治疗:构建混合护理未来状态的行动议程。
NAM Perspect. 2023 Oct 26;2023. doi: 10.31478/202310b. eCollection 2023.
9
Modality and terminology changes for behavioral health service delivery during the COVID-19 pandemic: a systematic review.2019冠状病毒病大流行期间行为健康服务提供的方式和术语变化:一项系统综述
Front Psychiatry. 2024 Feb 5;14:1265087. doi: 10.3389/fpsyt.2023.1265087. eCollection 2023.
10
Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed U.S. regulatory relaxations: A model-based analysis.拟议的美国监管放宽政策下阿片类药物使用障碍治疗的估计效果和成本效益:基于模型的分析。
Drug Alcohol Depend. 2024 Mar 1;256:111112. doi: 10.1016/j.drugalcdep.2024.111112. Epub 2024 Feb 1.

本文引用的文献

1
Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.健康中心对阿片类药物使用障碍实施远程医疗:对采用者和未采用者的定性评估。
J Subst Abuse Treat. 2020 Aug;115:108037. doi: 10.1016/j.jsat.2020.108037. Epub 2020 May 13.
2
How Is Telemedicine Being Used In Opioid And Other Substance Use Disorder Treatment?远程医疗在阿片类药物和其他物质使用障碍治疗中的应用方式有哪些?
Health Aff (Millwood). 2018 Dec;37(12):1940-1947. doi: 10.1377/hlthaff.2018.05134.
3
The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting.远程医疗提供的阿片类激动剂疗法在有监督的临床环境中的有效性。
Drug Alcohol Depend. 2017 Jul 1;176:133-138. doi: 10.1016/j.drugalcdep.2017.01.048. Epub 2017 May 17.
4
Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.远程精神病学与面对面丁丙诺啡药物辅助治疗阿片类物质使用障碍的治疗结果比较:一项为期2年的回顾性数据分析
J Addict Med. 2017 Mar/Apr;11(2):138-144. doi: 10.1097/ADM.0000000000000287.
5
Assessing Telemedicine Utilization by Using Medicaid Claims Data.利用医疗补助索赔数据评估远程医疗的使用情况。
Psychiatr Serv. 2017 Feb 1;68(2):173-178. doi: 10.1176/appi.ps.201500518. Epub 2016 Oct 3.
6
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.美国成瘾医学协会(ASAM)关于使用药物治疗阿片类药物使用成瘾的国家实践指南。
J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.
7
Emerging mHealth and eHealth interventions for serious mental illness: a review of the literature.针对严重精神疾病的新兴移动健康和电子健康干预措施:文献综述
J Ment Health. 2015;24(5):321-32. doi: 10.3109/09638237.2015.1019054. Epub 2015 May 28.
8
Provider barriers to telemental health: obstacles overcome, obstacles remaining.提供心理治疗的阻碍因素:已克服的障碍和仍存在的障碍。
Telemed J E Health. 2013 Jun;19(6):433-7. doi: 10.1089/tmj.2013.0068. Epub 2013 Apr 16.
9
Flexible work arrangements, job satisfaction, and turnover intentions: the mediating role of work-to-family enrichment.灵活的工作安排、工作满意度和离职意向:工作家庭增益的中介作用。
J Psychol. 2010 Jan-Feb;144(1):61-81. doi: 10.1080/00223980903356073.
10
Assessing the effectiveness of an Internet-based videoconferencing platform for delivering intensified substance abuse counseling.评估基于互联网的视频会议平台在提供强化药物滥用咨询方面的有效性。
J Subst Abuse Treat. 2009 Apr;36(3):331-8. doi: 10.1016/j.jsat.2008.06.011. Epub 2008 Sep 4.